Please login to the form below

Not currently logged in
Email:
Password:

PMHub

Welcome to PMHub, a unique resource brought to you by PMLive and designed to enable the Pharmaceutical industry’s key suppliers to present you with all the information you need to make an informed selection.
You will find a mix of in-depth profile, news, thought leadership and whitepapers within PMHub. If you are looking to find a company based on a particular area then please use the ‘profile’ search which will return a list of key companies offering the skills you are looking for.
If you are looking for a partner with a particular understanding or expertise then we recommend using the ‘resources’ search – which delivers a set of results based on the understanding and knowledge uploaded by the industry’s specialist agencies and suppliers.
If you are a supplier and would like to be included within PMHub please click the ‘Add my Company’ link below.

PMHub Profile Search

Add my company

Categories

Featured jobs

Latest content from PMHub

A Lucid Induction
Lucid Group kick off 2016 with six new employees Lucid Group Communications Limited
2016 brings new faces to emotive
emotive appoints Chloë Duval as the new Head of Copy, and Elise Payne joins as a Team Assistant. emotive
What pharma needs to know about genomic data in 2016
Consultant David Cooney from Blue Latitude Health talks us through what this progress in genomics means for pharma in 2016. Blue Latitude Health
Part Two: The First Amendment: Physician education using off-label indications to ensure that patients receive the most effective treatment.
In today’s medical environment there is a two-fold element of risk that affects a medical device company. It is comprised on the one hand by the risk of improper treatment through the agent’s lack of scientific disease state knowledge, and on the other by the medical device company’s fiduciary duty to ensure patient safety, including the facilitation of proper education to the physician. The body of law that regulates the marketing of medical device products in the United States is the Drug and Cosmetic Act, which places a restriction on off-label marketing and advertising. To date, proponents have argued that off-label utilization is a First Amendment right necessary to ensure that patients receive the most effective treatment. Nascent Medical LLC